2010 Perinatal GBS prevention guideline and resource utilization

Pediatrics

Volumn 133, Issue 2, 2014, Pages 196-203

  Mukhopadhyay, Sagori ^a,b   Dukhovny, Dmitry ^a,b,c   Mao, Wenyang ^c   Eichenwald, Eric C ^d   Puopolo, Karen M ^a,b,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Early onset sepsis; Group B Streptococcus; Intrapartum antibiotic prophylaxis; Neonatal infection

Indexed keywords

ANTIBIOTIC AGENT;

ALGORITHM; ARTICLE; BLOOD CELL COUNT; BLOOD CULTURE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; COST MINIMIZATION ANALYSIS; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; INFECTION RISK; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER;

EARLY-ONSET SEPSIS; GROUP B STREPTOCOCCUS; INTRAPARTUM ANTIBIOTIC PROPHYLAXIS; NEONATAL INFECTION;

ALGORITHMS; COHORT STUDIES; FEMALE; HEALTH RESOURCES; HUMANS; INFANT, NEWBORN; MALE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84893242338     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1866     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep. 1996;45(RR-7):1-24
2. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1-22
3. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10): 1-36
4. Boyer KM, Gotoff SP. Prevention of earlyonset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314(26):1665-1669
5. Schrag SJ, Zell ER, Lynfield R, et al Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347(4):233-239
6. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis. 1983;148(5):795-801
7. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis. 1990;162(3):672-677
8. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103(6). Available at: www.pediatrics.org/cgi/content/full/103/ 6/e77
9. Centers for Disease Control and Prevention (CDC). Early-onset and late-onset neonatal group B streptococcal disease - United States, 1996-2004. MMWR Morb Mortal Wkly Rep. 2005;54(47):1205-1208
10. Centers for Disease Control and Prevention (CDC). Trends in perinatal group B streptococcal disease - United States, 2000-2006. MMWR Morb Mortal Wkly Rep. 2009;58(5):109-112
11. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):937-941
12. Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics. 2010;125(5). Available at: www.pediatrics.org/cgi/content/full/125/5/e1031
13. Mukhopadhyay S, Eichenwald EC, Puopolo KM. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol. 2013;33(3):198-205
14. Dukhovny D, Zupancic JAF. Economic evaluation with clinical trials in neonatology. Neoreviews. 2011;12(2):e69-e75
15. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, eds. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford University Press; Oxford, England 2005
16. Greenwell EA, Wyshak G, Ringer SA, Johnson LC, Rivkin MJ, Lieberman E. Intrapartum temperature elevation, epidural use, and adverse outcome in term infants. Pediatrics. 2012;129(2). Available at: www.pediatrics.org/cgi/content/ full/129/2/e447
17. Lieberman E, Lang JM, Frigoletto F Jr, Richardson DK, Ringer SA, Cohen A. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics. 1997;99 (3):415-419
18. Agakidis C, Agakidou E, Philip Thomas S, Murthy P, John Lloyd D. Labor epidural analgesia is independent risk factor for neonatal pyrexia. J Matern Fetal Neonatal Med. 2011;24(9):1128-1132
19. Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J. 2003;22(5):430-434
20. Jackson GL, Engle WD, Sendelbach DM, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics. 2004;113(5):1173-1180
21. Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics. 2010;126(5): 903-909
22. Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31(8):799-802
23. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115(5):1240-1246
24. Platt R, Adelson-Mitty J, Weissman L, Zaleznik D, Lee ML, Baker CJ. Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease. Pediatr Infect Dis J. 1999;18(6):529-533
25. Turrentine MA, Ramirez MM, Mastrobattista JM. Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization. Infect Dis Obstet Gynecol. 2009;2009:934698
26. Ginsberg GM, Eidelman AI, Shinwell E, Anis E, Peyser R, Lotan Y. Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis. Isr J Health Policy Res. 2013;2(1):6
27. Berger MB, Xu X, Williams JA, Van de Ven CJ, Mozurkewich EL. Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis. BJOG. 2012;119(4):439-448
28. Rausch AV, Gross A, Droz S, Bodmer T, Surbek DV. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis. J Perinat Med. 2009;37(2):124-129
29. Brady MT, Polin RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics. 2013;132(1):166-168
30. Johnson L, Riley L, Lieberman E. Maternal and perinatal factors associated with early formula supplementation of breastfeeding in healthy term newborns. Poster Session: General Pediatrics & Preventive Pediatrics. E: PAS2012:4538.682 Pediatric Academic Societies Annual Meeting. Boston, Massachusetts: May 1, 2012
31. Johnson L, Riley L, Lieberman E. Impact of early separation from mother for sepsis evaluation on the timing of the first breastfeeding attempt in asymptomatic newborns. Poster Session: General Pediatrics & Preventive Pediatrics. E: PAS2012:4538.681 Pediatric Academic Societies Annual Meeting. Boston, Massachusetts: May 1, 2012